Verastem, Inc.
Verastem, Inc., a biopharmaceutical company, focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies. The indication in FL is approved under accelerated approval based on overall response rate. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being investigated in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), mesothelioma, and other solid tumors. Verastem, Inc. has collaboration agreements with Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited. The company was founded in 2010 and is based in Needham, Massachusetts. Show More...
-
Website http://www.verastem.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 4.96 USD
-
Last Updated 14-07-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.68 -1.7 -1.82 -2.07 -1.61 -0.99 -1.76 -1.37 -2.0 -1.83 Dividends USD Payout Ratio % * Shares Mil 20.0 19.0 23.0 26.0 36.0 37.0 38.0 69.0 75.0 83.0 Book Value Per Share * USD 4.44 5.0 3.26 3.04 2.23 0.81 1.46 0.27 0.76 Free Cash Flow Per Share * USD -1.22 -1.2 -1.4 -1.38 -0.91 -1.16 -1.35 -1.82 Return on Assets % -23.23 -42.1 -37.77 -47.67 -54.66 -37.05 -78.19 -39.47 -70.67 -66.04 Financial Leverage (Average) 1.03 1.07 1.11 1.1 1.16 1.56 2.23 20.22 1.69 Return on Equity % -669.32 -39.63 -51.76 -60.52 -41.7 -104.33 -79.61 -226.98 -141.03 Return on Invested Capital % -674.46 -39.83 -51.99 -60.87 -42.34 -84.95 -42.87 -73.99 -63.55 Interest Coverage -120.29 -11.47 -6.24 -4.66 Current Ratio 15.24 23.79 13.06 10.36 10.96 7.4 5.13 6.83 2.84 5.78 Quick Ratio 15.2 23.65 13.0 10.32 10.92 7.38 5.06 6.74 2.61 5.38 Debt/Equity 0.26 0.92 14.93 0.48